Oral clonidine treatment of congestive heart failure
    1.
    发明授权
    Oral clonidine treatment of congestive heart failure 失效
    口服可乐定治疗充血性心力衰竭

    公开(公告)号:US4603141A

    公开(公告)日:1986-07-29

    申请号:US676624

    申请日:1984-11-30

    申请人: Thomas D. Giles

    发明人: Thomas D. Giles

    IPC分类号: A61K31/415

    CPC分类号: A61K31/415

    摘要: Disclosed is a method of treating chronic congestive heart failure and particularly of increasing exercise tolerance in individuals so afflicted which comprises orally administering to such individuals a therapeutically effective amount of 2-[(2,6-dichlorophenyl)amino]-2-imidazoline or a nontoxic, pharmaceutically acceptable addition salt thereof. Such oral administration is preferably in an amount of at least about 0.1 mg/day for periods of at least about one week.

    摘要翻译: 本发明公开了一种治疗慢性充血性心力衰竭,特别是增加受累患者运动耐力的方法,其包括口服给予该个体治疗有效量的2 - [(2,6-二氯苯基)氨基] -2-咪唑啉或 无毒的药学上可接受的加成盐。 这样的口服给药优选为至少约0.1mg /天至少约一周的量。